Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HSD3B7 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | THOP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | SLC35A2 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | BLM | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | MMP24-AS1 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | VRK1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | PRKX | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PUM2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | INCENP | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |